ABBV vs LLY
ABBV and LLY side by side — valuation & fundamentals (public data).
Key statistics
| Metric | ABBVAbbVie Inc. | LLYELI LILLY AND COMPANY |
|---|---|---|
| Market cap | $464.74B | $1.07T |
| P/E (TTM) | 74.3 | 38.2 |
| P/B | — | 31.58 |
| P/S | 7.6x | 16.4x |
| Dividend yield | 2.51% | 0.50% |
| Revenue | $61.16B(TTM) | $79.67B(TTM) |
| Revenue growth (YoY) | 8.6% | 44.7% |
| Net income | $6.31B(TTM) | $26.71B(TTM) |
| Earnings growth (YoY) | -1.2% | 94.9% |
| EPS, diluted | $3.54(TTM) | $29.79(TTM) |
| EBIT margin | 24.6% | 40.2% |
| ROE | — | 60.9% |
| ROIC | 18.6% | 26.3% |
| 1y total return | +23.8% | +52.7% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: ABBV frente a LLY
| Métrica | ABBV | LLY |
|---|---|---|
| Valor final | $64.0K | $176.0K |
| Retorno total | +540.2% | +1660.0% |
| CAGR | +19.7% | +31.9% |
| Volatilidad | 25.9% | 30.1% |
| Sharpe | 0.67 | 0.94 |
| Sortino | 0.93 | 1.45 |
| Caída máxima | -45.1% | -34.5% |
Basado en 2600 días de negociación comunes, 2016-05-12 → 2026-09-15 · tasa libre de riesgo 4.11% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)